The markets closed modestly higher with the Dow rising 12 points to 16,817 despite disappointing economic data as investors focused on upbeat earnings. Nasdaq added 2 points to 4,485.
On the upside
The underwriters of Vitae Pharmaceuticals' (Nasdaq: VTAE) initial public offering exercised their option to purchase over 1 million shares of common stock at the IPO price of $8 per share.
Shares of Cyber-Ark Software (Nasdaq: CYBR) continued climbing.
Trex (NYSE: TREX) reversed year ago losses to post a profit for the third quarter as revenue climbed.
On the downside
Shares of Durect (Nasdaq: DRRX) plunged after Pfizer (NYSE: PFE) ended its partnership with Pain Therapeutics (Nasdaq: PTIE) to develop Remoxy. Pain had licensed the right to develop Remoxy from Durect.
GoPro (Nasdaq: GPRO) stock extended its losses.
Investors locked in profits on SodaStream International (Nasdaq: SODA)
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 4 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 slipped 2 points to 1961. Bitcoin slipped 2 points to $350.
Markets recover as investors focus on earnings
October 27, 2014 at 18:11 PM EDT